Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
Caocci, Giovanni
First
;Mulas, OlgaSecond
;Efficace, Fabio;Nasa, Giorgio LaLast
2020-01-01
File | Size | Format | |
---|---|---|---|
LDL.pdf open access
Type: versione editoriale
Size 655.55 kB
Format Adobe PDF
|
655.55 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.